MedTrace Logo

Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome

NCT03973996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-12-19

Study results available
· View outcomes & findings →

Summary

This study evaluates dietary green tea extract to improve gut health and inflammation in persons with metabolic syndrome and healthy adults. Participants will complete two phases of intervention in random order in which they will consume green tea extract or placebo for one month and then switch to the opposite treatment for an additional month.

Conditions

Interventions

DIETARY_SUPPLEMENT

Green Tea Extract

A gummy confection with catechin-rich green tea extract (1 g/d)

DIETARY_SUPPLEMENT

Placebo

A matched gummy confection formulated without green tea extract

Sponsors & Collaborators

  • United States Department of Agriculture (USDA)

    collaborator FED

  • Ohio State University

    lead OTHER

Principal Investigators

  • Richard S Bruno, PhD, RD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973996 on ClinicalTrials.gov